-
New Japanese Encephalitis Vaccine ‘A Historic Moment for Global Health’
As I prepare for retirement this month and reflect on my four years as the director of the neglected infectious diseases team here at the Bill & Melinda Gates Foundation, one of the things I am most proud of is to have been part of a global team that has been working to get a new Japanese encephalitis vaccine to the millions of people who need it.
- Categories
- Health Care
- Region
- Asia Pacific
- Tags
- vaccines
-
Crucial Vaccines Out of Reach for Many in Rural India
The Union health ministry's ambitious Mission Indradhanush to immunise children against various diseases faces a major challenge as the Hib vaccine to safeguard the little ones from deadly infections like meningitis, pneumonia and severe throat conditions remains out of the reach in vast areas of the country.
- Categories
- Health Care
- Region
- South Asia
-
GlaxoSmithKline and Merck Ebola Vaccines Succeed in Phase II Liberian Trials
Two Ebola vaccines, one developed by the NIH and GlaxoSmithKline ($GSK) and the other by Merck ($MRK) and NewLink ($NLNK), have sailed through Liberian trials and, based on the results, may now advance to Phase III trials.
- Categories
- Health Care
- Region
- Sub-Saharan Africa
-
Viewpoint: Where Do Vaccine Fears Come From?
In his 2013 New Yorker article “Slow Ideas,” the Harvard surgeon Atul Gawande offered a compelling way to understand why some good ideas spread slowly (if at all) while others spread like wildfire.
- Categories
- Health Care
- Tags
- vaccines
-
Microneedle Patches Could Be the Future of Vaccinations
Georgia Tech professor Mark Praunitz has spent two decades developing microneedle patches.
- Categories
- Health Care
- Tags
- vaccines
-
Viewpoint: Be Bold: How Gavi Will Immunise Another 300 Million Children
A challenge stands before us: ensuring immunisation of the world’s poorest children. If we, as global citizens can meet it, we will help protect the lives of millions in places too poor to afford vaccines.
- Categories
- Health Care
- Tags
- vaccines
-
Viewpoint: Not Free Vaccines, Mr. Gates, Just Sustainably-Priced Ones
Advocates working to increase global access to medicines were frustrated by the recent comments made by Bill Gates publicly criticizing Médecins Sans Frontières (Doctors without Borders, MSF) for calling for reductions in the prices of new vaccines. In doing so, Mr Gates stands by a system of pricing that requires raising billions of dollars in donor funding every year to support it. We believe that a system dependent on raising massive amounts of money to meet arbitrarily high prices set by the pharmaceutical industry is a failed system and should be acknowledged as such by donors like Mr Gates. Rather, true success in global vaccination requires mechanisms that can rapidly achieve long-term sustainable vaccine pricing.
- Categories
- Environment, Health Care
- Tags
- vaccines
-
Charity Attacks Gilead Over Hepatitis C Drug Restrictions
Charity Medecins Sans Frontieres has accused U.S. drugmaker Gilead Sciences Inc GILD.O of restricting access to its breakthrough hepatitis C drug Sovaldi in developing countries as it tries to protect profit margin in wealthier nations.
- Categories
- Health Care
- Tags
- philanthropy, vaccines
Subscribe to Our 'Business in Global Development' Newsletter!
Our new weekly LinkedIn newsletter features NextBillion's latest original articles, along with curated news, jobs, bizdev opportunities and events from our recent coverage of impact-focused business in emerging markets.
We respect your privacy. Your information is safe and will never be shared.
Don't miss out. Subscribe today.